Product Information
SIMPONI 50 MG/0.5 ML PEN INJEC is a brand product labeled by Janssen Biotech, Inc., priced at $12890.3164 per ML under NDC 57894007002. Its NADAC has been published 671 times since Nov 28, 2013.
Strength
50 mg/.5mL
Manufacturer
Janssen Biotech, Inc.NDC
57894007002
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Effective Date
9/23/2026
Active Ingredients
GOLIMUMABApproval Type
Biologic (BLA)
FDA Application
BLA125289On Market Since
4/25/2009
Pharmacological Classes
Price Statistics
The NADAC for SIMPONI 50 MG/0.5 ML PEN INJEC has been published 671 times since Nov 28, 2013, and over the history we have for it it has risen 162.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $12890.3164 per ML |
|---|---|
| All-time high | $12993.9000 (Jun 10, 2026) |
| All-time low | $4914.9886 (Nov 28, 2013) |
| 52-week high | $12993.9000 |
| 52-week low | $12352.9330 |
| Median price | $9761.0524 |
| Average price | $9460.5154 |
| Largest weekly change | +9.9% (Aug 13, 2014) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Janssen Biotech, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
golimumab market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Tumor Necrosis Factor Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SIMPONI 50 MG/0.5 ML PEN INJEC?
The current National Average Drug Acquisition Cost (NADAC) for SIMPONI 50 MG/0.5 ML PEN INJEC, manufactured by Janssen Biotech, Inc., is $12890.3164 per ML (NDC 57894007002), effective Sep 30, 2026.
How has the price of SIMPONI 50 MG/0.5 ML PEN INJEC changed over time?
Over the history we have for it, the NADAC for SIMPONI 50 MG/0.5 ML PEN INJEC has risen 162.3%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for SIMPONI 50 MG/0.5 ML PEN INJEC?
Since Nov 28, 2013, the NADAC for SIMPONI 50 MG/0.5 ML PEN INJEC has ranged from a low of $4914.9886 (Nov 28, 2013) to a high of $12993.9000 (Jun 10, 2026), with a median of $9761.0524 per ML.
Are there cheaper alternatives to SIMPONI 50 MG/0.5 ML PEN INJEC?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as SIMPONI 50 MG/0.5 ML PEN INJEC in a comparable dosage form, but none are currently priced below it.
Who manufactures SIMPONI 50 MG/0.5 ML PEN INJEC?
SIMPONI 50 MG/0.5 ML PEN INJEC (NDC 57894007002) is labeled by Janssen Biotech, Inc., and CMS classifies it as a brand product.